Invention Grant
- Patent Title: Peptide pharmaceuticals for insulin resistance
-
Application No.: US15820127Application Date: 2017-11-21
-
Publication No.: US10577405B2Publication Date: 2020-03-03
- Inventor: John J. Nestor
- Applicant: Mederis Diabetes LLC
- Applicant Address: US TX Sugar Land
- Assignee: Mederis Diabetes LLC
- Current Assignee: Mederis Diabetes LLC
- Current Assignee Address: US TX Sugar Land
- Agent Koren Anderson
- Main IPC: A61K38/26
- IPC: A61K38/26 ; C07K14/605 ; A61K47/54 ; A61K47/64 ; A61K38/00
Abstract:
Described herein are methods of syntheses and therapeutic uses of covalently modified peptides and/or proteins. The covalently modified peptides and/or proteins allow for improved pharmaceutical properties of peptide and protein-based therapeutics.
Public/Granted literature
- US20180194826A1 PEPTIDE PHARMACEUTICALS FOR INSULIN RESISTANCE Public/Granted day:2018-07-12
Information query
IPC分类:
